TransMedics to Present at Upcoming March Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN

6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Get Alerts TMDX Hot Sheet

Price: $70.74 -1.83%

Overall Analyst Rating:
SELL (= Flat)

Revenue Growth %: +23.5%

Join SI Premium – FREE

ANDOVER, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Cowen 43rd Annual Healthcare Conference in Boston on Monday, March 6, 2023, at 9:10 a.m. EST and to present virtually at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, at 12:00 p.m. EST.

Event: Cowen 43rd Annual Healthcare ConferenceDate: Monday, March 6, 2023Time: 9:10 a.m. EST

Event: Oppenheimer 33rd Annual Healthcare ConferenceDate: Monday, March 13, 2022Time: 12:00 p.m. EST

A live and archived webcast of the presentations will be available on the “Investors” section of the TransMedics website at https://investors.transmedics.com/.

About TransMedics Group, Inc. TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:Brian Johnston332-895-3222[email protected]